Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-09-24 Purchase | 2024-09-26 09:33 am | Reneo Pharmaceuticals Inc. | RPHM | Leonard Braden Michael 10% Owner | 98,346 | $1.4717 | $144,738 | 4,478,164 (Indirect Direct) | View |
2024-09-17 Purchase | 2024-09-19 11:02 am | Reneo Pharmaceuticals Inc. | RPHM | Leonard Braden Michael 10% Owner | 56,106 | $1.3588 | $76,237 | 4,379,818 (Indirect Direct) | View |
2024-09-12 Purchase | 2024-09-16 4:15 pm | Reneo Pharmaceuticals Inc. | RPHM | Leonard Braden Michael 10% Owner | 358,923 | $1.3494 | $484,344 | 4,323,712 (Indirect Direct) | View |
2024-09-05 Purchase | 2024-09-09 4:24 pm | Talis Biomedical Corp | TLIS | Leonard Braden Michael 10% Owner | 30,100 | $1.4698 | $44,240 | 248,702 (Indirect) | View |
2024-09-03 Purchase | 2024-09-05 11:57 am | Talis Biomedical Corp | TLIS | Leonard Braden Michael 10% Owner | 500 | $4 | $2,000 | 218,602 (Indirect) | View |
2024-08-30 Purchase | 2024-09-04 8:19 pm | Talis Biomedical Corp | TLIS | Leonard Braden Michael 10% Owner | 151 | $4.25 | $642 | 218,602 (Indirect) | View |
2024-08-26 Purchase | 2024-08-28 4:45 pm | Talis Biomedical Corp | TLIS | Leonard Braden Michael 10% Owner | 14,382 | $3.9033 | $56,137 | 217,951 (Indirect) | View |
2024-08-13 Purchase | 2024-08-14 8:48 pm | Reneo Pharmaceuticals Inc. | RPHM | Leonard Braden Michael 10% Owner | 271,826 | $1.4002 | $380,598 | 3,964,789 (Indirect Direct) | View |
2024-08-14 Purchase | 2024-08-14 8:24 pm | AN2 Therapeutics Inc. | ANTX | Leonard Braden Michael 10% Owner | 1,500,000 | $1.04 | $1,560,000 | 5,749,432 (Indirect) | View |
2024-08-02 Purchase | 2024-08-05 3:57 pm | Aclaris Therapeutics Inc. | ACRS | Leonard Braden Michael 10% Owner | 373,569 | $1.2655 | $472,757 | 14,250,000 (Indirect) | View |
2024-07-30 Purchase | 2024-07-31 4:19 pm | Adverum Biotechnologies Inc. | ADVM | Leonard Braden Michael 10% Owner | 85,800 | $7.15 | $613,470 | 2,372,864 (Indirect Direct) | View |
2024-07-30 Purchase | 2024-07-31 4:10 pm | Aclaris Therapeutics Inc. | ACRS | Leonard Braden Michael 10% Owner | 273,730 | $1.3115 | $359,010 | 13,876,421 (Indirect) | View |
2024-07-18 Purchase | 2024-07-22 4:03 pm | Aclaris Therapeutics Inc. | ACRS | Leonard Braden Michael 10% Owner | 154,722 | $1.3043 | $201,808 | 13,602,691 (Indirect) | View |
2024-07-17 Purchase | 2024-07-18 9:16 pm | Adverum Biotechnologies Inc. | ADVM | Leonard Braden Michael 10% Owner | 216,264 | $8.2569 | $1,785,662 | 2,287,064 (Indirect Direct) | View |
2024-07-02 Purchase | 2024-07-05 2:46 pm | Aclaris Therapeutics Inc. | ACRS | Leonard Braden Michael 10% Owner | 352,397 | $1.1518 | $405,894 | 13,447,969 (Indirect) | View |
2024-06-27 Purchase | 2024-07-01 1:39 pm | Aclaris Therapeutics Inc. | ACRS | Leonard Braden Michael 10% Owner | 1,543,434 | $1.1287 | $1,742,075 | 13,095,572 (Indirect) | View |
2024-06-14 Purchase | 2024-06-18 4:04 pm | Aclaris Therapeutics Inc. | ACRS | Leonard Braden Michael 10% Owner | 545,000 | $1.1527 | $628,206 | 11,552,134 (Indirect) | View |
2024-06-11 Purchase | 2024-06-13 6:04 pm | Aclaris Therapeutics Inc. | ACRS | Leonard Braden Michael 10% Owner | 1,611,200 | $1.1059 | $1,781,897 | 11,007,134 (Indirect) | View |
2024-05-14 Purchase | 2024-05-16 08:58 am | Reneo Pharmaceuticals Inc. | RPHM | Leonard Braden Michael 10% Owner | 414,281 | $1.5438 | $639,578 | 3,692,963 (Indirect Direct) | View |
2024-05-13 Purchase | 2024-05-15 11:21 am | AVROBIO Inc. | AVRO | Leonard Braden Michael 10% Owner | 766,635 | $1.2672 | $971,493 | 5,168,262 (Indirect Direct) | View |
2024-03-20 Purchase | 2024-03-25 11:05 am | Cyteir Therapeutics Inc. | CYT | Leonard Braden Michael 10% Owner | 170,589 | $2.95 | $503,238 | 3,989,053 (Indirect Direct) | View |
2024-03-18 Purchase | 2024-03-19 4:19 pm | Cyteir Therapeutics Inc. | CYT | Leonard Braden Michael 10% Owner | 113,777 | $3.01 | $342,469 | 3,818,464 (Indirect Direct) | View |
2023-01-03 Sale(A) | 2023-01-05 8:03 pm | IMARA Inc. | IMRA | Leonard Braden Michael 10% Owner | 1,250,000 | $4 | $5,000,000 | 1,997,774 (Indirect Direct) | View |
2023-01-04 Sale | 2023-01-04 7:49 pm | IMARA Inc. | IMRA | Leonard Braden Michael 10% Owner | 1,250,000 | $4 | $5,000,000 | 1,997,774 (Indirect Direct) | View |
2022-12-30 Sale | 2022-12-30 5:42 pm | IMARA Inc. | IMRA | Leonard Braden Michael 10% Owner | 20,000 | $4.04 | $80,800 | 3,247,774 (Indirect Direct) | View |
2022-12-28 Sale | 2022-12-29 6:18 pm | IMARA Inc. | IMRA | Leonard Braden Michael 10% Owner | 20,000 | $4.04 | $80,800 | 3,267,774 (Indirect Direct) | View |
2022-12-29 Sale | 2022-12-29 5:43 pm | RETRACTABLE TECHNOLOGIES INC | RVP | Leonard Braden Michael 10% Owner | 3,000,000 | $1.6 | $4,800,000 | 1,076,075 (Indirect Direct) | View |
2022-12-22 Sale | 2022-12-27 09:34 am | IMARA Inc. | IMRA | Leonard Braden Michael 10% Owner | 50,000 | $4.06 | $203,000 | 3,287,774 (Indirect Direct) | View |
2022-12-19 Purchase | 2022-12-21 5:49 pm | Metacrine Inc. | MTCR | Leonard Braden Michael 10% Owner | 271,605 | $0.39614 | $107,594 | 6,760,570 (Indirect Direct) | View |
2022-12-02 Purchase | 2022-12-02 6:38 pm | ASTROTECH Corp | ASTC | Leonard Braden Michael 10% Owner | 190,971 | $0.3435 | $65,599 | 6,962,311 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-10-07 Other | 2024-10-09 11:25 am | N/A N/A | OnKure Therapeutics Inc. | OKUR | Leonard Braden Michael Former 10% owner of RPHM | 447,815 | $0 | 895,630 (Indirect) | View |
Ownership | 2024-08-14 9:13 pm | N/A N/A | Talis Biomedical Corp | TLIS | Leonard Braden Michael 10% Owner | 0 | $0 | 203,569 (Indirect) | View |
Ownership | 2024-08-12 4:58 pm | N/A N/A | AN2 Therapeutics Inc. | ANTX | Leonard Braden Michael 10% Owner | 0 | $0 | 4,249,432 (Indirect) | View |
Ownership | 2024-07-18 9:16 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Leonard Braden Michael 10% Owner | 0 | $0 | 2,207,976 (Indirect) | View |
2024-06-20 Other | 2024-06-25 1:42 pm | N/A N/A | Tectonic Therapeutic Inc. | TECX | Leonard Braden Michael Former 10% owner of AVROBIO | 433,688 | $0 | 867,376 (Indirect) | View |
Ownership | 2024-05-16 08:56 am | N/A N/A | Reneo Pharmaceuticals Inc. | RPHM | Leonard Braden Michael 10% Owner | 0 | $0 | 3,692,963 (Indirect) | View |
Ownership(A) | 2024-05-15 10:51 am | N/A N/A | AVROBIO Inc. | AVRO | Leonard Braden Michael 10% Owner | 0 | $0 | 4,871,380 (Indirect) | View |
Ownership | 2024-05-15 10:31 am | N/A N/A | AVROBIO Inc. | AVRO | Leonard Braden Michael 10% Owner | 0 | $0 | 4,471,380 (Indirect) | View |
Ownership | 2024-03-19 4:09 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | Leonard Braden Michael 10% Owner | 0 | $0 | 3,704,687 (Indirect) | View |
Ownership | 2024-02-08 10:47 am | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Leonard Braden Michael 10% Owner | 0 | $0 | 9,395,934 (Indirect) | View |